Responsiveness of the Motor Function Measure in Patients With Spinal Muscular Atrophy.
Vuillerot C, Payan C, Iwaz J, Ecochard R, Bérard C and the MFM Spinal Muscular Atrophy Study Group.
Arch Phys Med Rehabil. 2013. 94(8) : 1555-61.
Assessment in 112 patients with Spinal Muscular Atrophy (SMA) aged 5.7 to 59 years of the ability of the MFM to detect changes in the progression of SMA. In patients with SMA type 2 and type 3, there was a moderate inverse relationship between age and the MFM total score. Patients with less than 6 months’ follow-up showed little score changes. Patients with a longer follow-up showed a slow deterioration (-0.9 points/y for type 2 and -0.6 points/y for type 3). Substantial responsiveness was obtained with the MFM D2 subscore (proximal and axial motricity) in patients with SMA type 2, and with the MFM D1 subscore (standing and transfers) in patients with SMA type 3.
Keywords: Clinical trial, Mobility limitation, Muscle weakness, Spinal Muscular Atrophy, Neuromuscular diseases, Rehabilitation
Articles dans les revues scientifiques
Fonction musculaire et atteinte d’organes dans la dystrophie myotonique de type 1
Pruna L, Machado F, Louis L, Vassé G, Kaminsky P. Revue Neurologie 2011. 167: 23-28. The aim of this study, carried out on 69 patients with type 1 myotonic dystrophy, was to assess the correlations between the MFM score and some organ impairments. The MFM provides an...
Regional body composition and functional impairment in patients with Myotonic Dystrophy
Pruna L, Chatelin J, Pascal-Vigneron V, Kaminsky P. Muscle nerve 2011. 44(4) : 503-8. In this study, fat-free mass index (FFMI), fat mass index (FMI) and functional impairment were examined in 48 patients with myotonic dystrophy type 1 subjects and anthropometrically...
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group. Lancet Neurol 2010. 9(1):77-93. The MFM is quoted in this article as an...
Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.
Jansen M, de Groot IJ, van Alfen N, Geurts AC. BMC Pediatr 2010. 10: 55. The protocol of the NUD (No Use is disuse) study aims to assess whether a low-intensity physical training in DMD patients is beneficial in terms of preserving muscle endurance and functional...
Analyse de la validité de la MFM en pratique clinique de consultation adulte d’un centre de référence pour maladies neuromusculaires
Benaïm C, Sacconi S, Fournier-Mehouas M, Tanant V, Desnuelle C. Revue Neurologie 2010. 166 : 49-53. Between 2005 and 2007, among 100 adults (18-78y) with Steinert myotonic dystrophy or facio-scapulohuméral dystrophy randomly selected in reference center of Nice...
Neuromuscular diseases and useful instruments in the motor evaluation of children and adolescents
Diniz GPC, Lasmar LMLB, Giannetti JG. Revista Médica de Minas Gerais. 2010. 20(4 Supl 3): S12-S19. Bibliographic review of the most common neuromuscular diseases in children and measurement scales, including MFM, used for the evaluation of these patients.LinkKeywords:...